4.5 Article

Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression

期刊

NEUROBIOLOGY OF AGING
卷 37, 期 -, 页码 -

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2015.09.014

关键词

Parkinson disease; Age at onset; Motor progression; GBA; SNCA; MAPT

资金

  1. NINDS [NS075321, NS41509, NS058714, R01AG044546]
  2. Barnes Jewish Hospital Foundation (BJHF)
  3. American Parkinson Disease Association (APDA) Advanced Research Center for Parkinson Disease at Washington University in St. Louis
  4. Greater St. Louis Chapter of the APDA
  5. Barnes Jewish Hospital Foundation (Elliot Stein Family Fund)
  6. Barnes Jewish Hospital Foundation (Parkinson Disease Research Fund)
  7. Michael J. Fox Foundation for Parkinson's Research
  8. Alzheimer's Association
  9. Weston Brain Institute
  10. American Federation for Aging Research
  11. BrightFocus Foundation Alzheimer's Disease Research Grant [A2013359S]
  12. Abbvie
  13. Avid Radiopharmaceuticals
  14. Biogen Idec
  15. Bristol-Myers Squibb
  16. Covance
  17. GE Healthcare
  18. Genentech
  19. GlaxoSmithKline
  20. Lilly
  21. Lundbeck
  22. Merck
  23. Meso Scale Discovery
  24. Pfizer
  25. Piramal
  26. Roche
  27. UCB
  28. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041509, R01NS058714, R01NS075321] Funding Source: NIH RePORTER
  29. NATIONAL INSTITUTE ON AGING [RF1AG044546, R01AG044546] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Multiple genetic variants have been linked to risk of Parkinson disease (PD), but known mutations do not explain a large proportion of the total PD cases. Similarly, multiple loci have been associated with PD risk by genome-wide association studies (GWAS). The influence that genetic factors confer on phenotypic diversity remains unclear. Few studies have been performed to determine whether the GWAS loci are also associated with age at onset (AAO) or motor progression. We used 2 PD case-control data sets (Washington University and the Parkinson's Progression Markers Initiative) to determine whether polymorphisms located at the GWAS top hits (GBA, ACMSD/TMEM163, STK39, MCCC1/LAMP3, GAK/TMEM175, SNCA, and MAPT) show association with AAO or motor progression. We found associations between single nucleotide polymorphisms at the GBA and MAPT loci and PD AAO and progression. These findings reinforce the complex genetic basis of PD and suggest that distinct genes and variants explain the genetic architecture of PD risk, onset, and progression. (C) 2016 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据